v1
Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT).
Identifier:nobleid.org/w1/20260515/7D2B3DAC
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/7D2B3DAC)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims